Is Pavmed Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PAVM) stock is to Hold PAVM stock.
Out of 1 analyst, 0 (0%) are recommending PAVM as a Strong Buy, 0 (0%) are recommending PAVM as a Buy, 1 (100%) are recommending PAVM as a Hold, 0 (0%) are recommending PAVM as a Sell, and 0 (0%) are recommending PAVM as a Strong Sell.
What is PAVM's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: PAVM) forecast ROE is N/A, which is considered weak.
What is PAVM's Price Target?
According to 1 Wall Street analyst that have issued a 1 year PAVM price target, the average PAVM price target is $1.40, with the highest PAVM stock price forecast at $1.40 and the lowest PAVM stock price forecast at $1.40.
The Wall Street analyst predicted that Pavmed's share price could reach $1.40 by Aug 18, 2024. The average Pavmed stock price prediction forecasts a potential upside of 338.87% from the current PAVM share price of $0.32.
What is PAVM's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: PAVM) forecast ROA is -190.95%, which is lower than the forecast US Medical Devices industry average of 8.14%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.